User Profile
Corporate
Careers
FAQ
Blog
Pricing
Social
General Modals
Advanced Modals
Search
Wizards
T1D Innovation Grant Program
T1D is a chronic autoimmune condition that imposes a lifelong burden on affected individuals, impacting their physical, psychosocial, and socioeconomic well-being.1-3 The progressive destruction of insulin-producing beta cells and consequent insulin deficiency can result in severe acute complications like diabetic ketoacidosis (DKA), which is common at diagnosis and can have life-threatening acute and long-term consequences, including brain changes and increased morbidity and mortalit
Specialties
Eligibility Requirements
We seek innovative research projects that explore translational immunology in T1D. Areas of interest within the scope of this initiative include:
- Novel pathways of autoimmunity in T1D
- New approaches to early detection of at-risk individuals
- Biomarker strategies, especially for prediction of T1D disease progression, and for stratification for clinical response to immunotherapy
- Applications of artificial intelligence and/or machine learning in any of the above research topics
Eligible Countries:
Sponsor Details
Sponsor Institute/Organizations: Sanofi
Sponsor Type: Corporate/Non-Profit
Address: 46-48 Av. De La Grande Armée, Paris, Ile-de-France, 75017, France
Legal & Affiliation Disclaimer
Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.
Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.
Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.
Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.
Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.
Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.
Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.
Grant
Letter Of Intent Deadline:
Dec 19, 2025
Final Deadline:
Dec 19, 2025
Funding Amount:
$161,886
5 awards available. €140,000
Host Details
Affiliation: Sanofi
Address: 46-48 Av. De La Grande Armée, Paris, Ile-de-France, 75017, France
Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.
Invite Gmail Contacts